摘要
目的探讨介入溶栓治疗急性脑梗塞的临床疗效、安全性。方法35例起病在24h内的急性脑梗塞患者接受动脉溶栓治疗,并采取欧洲卒中量表(ESS)及Barthel指数(BI)评价神经功能的恢复情况。结果介入溶栓后患者ESS评分明显增加,介入溶栓组与对照组间有显著差异。发病6h内介入溶栓治疗患者闭塞血管完全再通及部分再通率为13/13(100%)、颅内出血率为0.00%;发病24h内介入溶栓后患者闭塞血管完全再通及部分再通为26/35,颅内脑出血发生率为5.71%,无一例死于实质性出血。结论起病6h内,介入溶栓治疗急性脑梗塞安全、有效。
Objective To evaluate the clinical efficacy and safety of interventional therapy for acute cerebral infarction. Method Using urokinase, 35 patients with acute cerebral infarction within 24 hours were treated by intra-artery thrombolytic therapy, Europe stroke scale (ESS), Barthel index (BI) were used to evaluate the recovery of neurological function. Result ESS scores increase rapidly after thrombolytisis, and there were significant difference between the two teams. Thirteen of 13 cases treated within 6 hours from onset showed complete/partial recanalization in cerebral angiography and intraparenchymal hemorrhagic rate were 0%, twenty-six of 35 cases treated within 24 hours showed complete/partial recanalization and intraparenchymal hemorrhagic rate were 5.71%. Conclusion Interventional therapy for acute cerebral infarction within 6h were safe and effective.
出处
《影像诊断与介入放射学》
2004年第4期232-234,共3页
Diagnostic Imaging & Interventional Radiology
